Hypermethylation of the HADH gene has been identified as one mechanism underlying its downregulation in CRC, where it modulates cancer cell proliferation through the Wnt/β-catenin and Wnt/ROR2/DVL2 signaling pathways (46, 51). This evidence concerns the gene HADH and cancer.